Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Consolidated Net Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,885 Cr₹1,388 Cr₹715 Cr₹170 Cr₹441 Cr

What is the latest Consolidated Net Profit of NATCO PHARMA ?

The latest Consolidated Net Profit ratio of NATCO PHARMA is ₹1,885 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,885 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹441 Cr

How is Consolidated Net Profit of NATCO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,885 Cr
35.81
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.44
Mar2021 ₹441 Cr -

Compare Consolidated Net Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹20,130.8 Cr 2.2% 14.2% 24% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 5.2% 3.8% -1.8% Stock Analytics
DIVIS LABORATORIES ₹176,618.0 Cr 2.2% 11.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 0.8% 0.7% 25.7% Stock Analytics
CIPLA ₹107,722.0 Cr 1.3% 9.1% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -3.5% 2.7% 10.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.2%

14.2%

24%

SENSEX

-0.4%

7.1%

-4%


You may also like the below Video Courses